CZ20033042A3 - Potravinový doplněk na bázi silymarinu - Google Patents

Potravinový doplněk na bázi silymarinu Download PDF

Info

Publication number: CZ20033042A3
Authority: CZ; Czechia
Prior art keywords: silymarin; weight; food supplement; based food; extract
Prior art date: 2003-11-10

Application number

CZ20033042A

Other languages

Czech (cs)

English (en)

Other versions

CZ295149B6 (cs

Inventor

Nina Doc. Rndr. Csc. Škottová

Jitka Prof. Rndr. Csc Ulrichová

Drsc. Šimánek Vilím Prof. Mudr. Csc.

Milan Pharmdr. Krajíček

Karel Ing. Adamec

Original Assignee

Naturprodukt Cz Spol. S R. O.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-11-10

Filing date

2003-11-10

Publication date

2005-06-15

2003-11-10 Application filed by Naturprodukt Cz Spol. S R. O. filed Critical Naturprodukt Cz Spol. S R. O.

2003-11-10 Priority to CZ20033042A priority Critical patent/CZ20033042A3/cs

2004-01-13 Priority to SK32-2004A priority patent/SK322004A3/sk

2004-01-13 Priority to SK50027-2009U priority patent/SK5336Y1/sk

2004-10-26 Priority to PL370897A priority patent/PL205939B1/pl

2004-11-08 Priority to DE102004054133A priority patent/DE102004054133A1/de

2004-11-08 Priority to DE202004021241U priority patent/DE202004021241U1/de

2005-06-15 Publication of CZ295149B6 publication Critical patent/CZ295149B6/cs

2005-06-15 Publication of CZ20033042A3 publication Critical patent/CZ20033042A3/cs

Links

SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 title claims abstract description 43
SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 title claims abstract description 42
229960004245 silymarin Drugs 0.000 title claims abstract description 38
235000017700 silymarin Nutrition 0.000 title claims abstract description 38
235000015872 dietary supplement Nutrition 0.000 title claims abstract description 18
239000000284 extract Substances 0.000 claims abstract description 13
235000005911 diet Nutrition 0.000 claims abstract description 12
230000037213 diet Effects 0.000 claims abstract description 11
239000000203 mixture Substances 0.000 claims abstract description 8
239000004480 active ingredient Substances 0.000 claims abstract description 7
201000010099 disease Diseases 0.000 claims abstract description 7
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 7
235000003406 Polymnia sonchifolia Nutrition 0.000 claims abstract description 6
230000008092 positive effect Effects 0.000 claims abstract description 5
241001103520 Smallanthus sonchifolius Species 0.000 claims abstract 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
229920000168 Microcrystalline cellulose Polymers 0.000 claims description 4
239000000945 filler Substances 0.000 claims description 4
235000019813 microcrystalline cellulose Nutrition 0.000 claims description 4
239000008108 microcrystalline cellulose Substances 0.000 claims description 4
229940016286 microcrystalline cellulose Drugs 0.000 claims description 4
230000001603 reducing effect Effects 0.000 claims description 4
229920002261 Corn starch Polymers 0.000 claims description 3
239000008120 corn starch Substances 0.000 claims description 3
239000000314 lubricant Substances 0.000 claims description 3
239000000377 silicon dioxide Substances 0.000 claims description 3
229920000881 Modified starch Polymers 0.000 claims description 2
239000004368 Modified starch Substances 0.000 claims description 2
235000021355 Stearic acid Nutrition 0.000 claims description 2
CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims description 2
239000008116 calcium stearate Substances 0.000 claims description 2
235000013539 calcium stearate Nutrition 0.000 claims description 2
235000019426 modified starch Nutrition 0.000 claims description 2
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 2
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 2
229920001592 potato starch Polymers 0.000 claims description 2
239000008117 stearic acid Substances 0.000 claims description 2
239000000454 talc Substances 0.000 claims description 2
229910052623 talc Inorganic materials 0.000 claims description 2
LRCFXGAMWKDGLA-UHFFFAOYSA-N dioxosilane;hydrate Chemical compound O.O=[Si]=O LRCFXGAMWKDGLA-UHFFFAOYSA-N 0.000 claims 1
229960004029 silicic acid Drugs 0.000 claims 1
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 14
230000000694 effects Effects 0.000 description 12
244000272459 Silybum marianum Species 0.000 description 8
235000012000 cholesterol Nutrition 0.000 description 7
239000000902 placebo Substances 0.000 description 7
229940068196 placebo Drugs 0.000 description 7
150000003626 triacylglycerols Chemical class 0.000 description 7
230000003078 antioxidant effect Effects 0.000 description 6
239000003963 antioxidant agent Substances 0.000 description 5
235000006708 antioxidants Nutrition 0.000 description 5
244000134540 Polymnia sonchifolia Species 0.000 description 4
241000700159 Rattus Species 0.000 description 4
235000010841 Silybum marianum Nutrition 0.000 description 4
239000008280 blood Substances 0.000 description 4
210000004369 blood Anatomy 0.000 description 4
239000000890 drug combination Substances 0.000 description 4
210000004185 liver Anatomy 0.000 description 4
235000013406 prebiotics Nutrition 0.000 description 4
238000002360 preparation method Methods 0.000 description 4
229950000628 silibinin Drugs 0.000 description 4
235000014899 silybin Nutrition 0.000 description 4
208000004930 Fatty Liver Diseases 0.000 description 3
108090001030 Lipoproteins Proteins 0.000 description 3
102000004895 Lipoproteins Human genes 0.000 description 3
239000002775 capsule Substances 0.000 description 3
239000003814 drug Substances 0.000 description 3
150000002632 lipids Chemical class 0.000 description 3
239000002417 nutraceutical Substances 0.000 description 3
235000021436 nutraceutical agent Nutrition 0.000 description 3
235000020777 polyunsaturated fatty acids Nutrition 0.000 description 3
SEBFKMXJBCUCAI-WAABAYLZSA-N (2r,3r)-3,5,7-trihydroxy-2-[(2s,3s)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydrochromen-4-one Chemical compound C1=C(O)C(OC)=CC([C@H]2[C@@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-WAABAYLZSA-N 0.000 description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
208000031226 Hyperlipidaemia Diseases 0.000 description 2
208000001145 Metabolic Syndrome Diseases 0.000 description 2
241000320380 Silybum Species 0.000 description 2
108010062497 VLDL Lipoproteins Proteins 0.000 description 2
201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 2
230000000923 atherogenic effect Effects 0.000 description 2
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
229940099112 cornstarch Drugs 0.000 description 2
229940079593 drug Drugs 0.000 description 2
235000013305 food Nutrition 0.000 description 2
239000008103 glucose Substances 0.000 description 2
230000003647 oxidation Effects 0.000 description 2
238000007254 oxidation reaction Methods 0.000 description 2
230000002265 prevention Effects 0.000 description 2
239000000126 substance Substances 0.000 description 2
DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
241000208838 Asteraceae Species 0.000 description 1
241001233914 Chelidonium majus Species 0.000 description 1
JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
206010016654 Fibrosis Diseases 0.000 description 1
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
244000044980 Fumaria officinalis Species 0.000 description 1
235000006961 Fumaria officinalis Nutrition 0.000 description 1
108010023302 HDL Cholesterol Proteins 0.000 description 1
206010019708 Hepatic steatosis Diseases 0.000 description 1
239000009095 Hepatofalk Substances 0.000 description 1
206010060378 Hyperinsulinaemia Diseases 0.000 description 1
206010020772 Hypertension Diseases 0.000 description 1
108010028554 LDL Cholesterol Proteins 0.000 description 1
108010007622 LDL Lipoproteins Proteins 0.000 description 1
102000007330 LDL Lipoproteins Human genes 0.000 description 1
241000801963 Lebeda Species 0.000 description 1
208000008589 Obesity Diseases 0.000 description 1
240000001090 Papaver somniferum Species 0.000 description 1
235000008753 Papaver somniferum Nutrition 0.000 description 1
235000001537 Ribes X gardonianum Nutrition 0.000 description 1
235000001535 Ribes X utile Nutrition 0.000 description 1
235000016919 Ribes petraeum Nutrition 0.000 description 1
244000281247 Ribes rubrum Species 0.000 description 1
235000002355 Ribes spicatum Nutrition 0.000 description 1
108010069201 VLDL Cholesterol Proteins 0.000 description 1
238000000540 analysis of variance Methods 0.000 description 1
230000003178 anti-diabetic effect Effects 0.000 description 1
239000003472 antidiabetic agent Substances 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
229940094199 black currant oil Drugs 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
235000010980 cellulose Nutrition 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
230000001989 choleretic effect Effects 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
229940052810 complex b Drugs 0.000 description 1
229910001431 copper ion Inorganic materials 0.000 description 1
238000009223 counseling Methods 0.000 description 1
239000000824 cytostatic agent Substances 0.000 description 1
230000001085 cytostatic effect Effects 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
230000000378 dietary effect Effects 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
239000000428 dust Substances 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
230000004761 fibrosis Effects 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
239000007903 gelatin capsule Substances 0.000 description 1
230000002440 hepatic effect Effects 0.000 description 1
230000002443 hepatoprotective effect Effects 0.000 description 1
231100000334 hepatotoxic Toxicity 0.000 description 1
230000003082 hepatotoxic effect Effects 0.000 description 1
230000000055 hyoplipidemic effect Effects 0.000 description 1
230000003451 hyperinsulinaemic effect Effects 0.000 description 1
201000008980 hyperinsulinism Diseases 0.000 description 1
208000006575 hypertriglyceridemia Diseases 0.000 description 1
230000000999 hypotriglyceridemic effect Effects 0.000 description 1
230000003308 immunostimulating effect Effects 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
230000037356 lipid metabolism Effects 0.000 description 1
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Substances [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
229940096421 milk thistle extract Drugs 0.000 description 1
235000020727 milk thistle extract Nutrition 0.000 description 1
229940106589 milk thistle seed extract Drugs 0.000 description 1
235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
235000020824 obesity Nutrition 0.000 description 1
239000003921 oil Substances 0.000 description 1
235000019198 oils Nutrition 0.000 description 1
230000001590 oxidative effect Effects 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
230000003449 preventive effect Effects 0.000 description 1
230000000207 pro-atherogenic effect Effects 0.000 description 1
239000000047 product Substances 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
235000003441 saturated fatty acids Nutrition 0.000 description 1
235000012239 silicon dioxide Nutrition 0.000 description 1
238000007619 statistical method Methods 0.000 description 1
235000000346 sugar Nutrition 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
239000013589 supplement Substances 0.000 description 1
238000009120 supportive therapy Methods 0.000 description 1
238000012360 testing method Methods 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Nutrition Science (AREA)
Endocrinology (AREA)
Gastroenterology & Hepatology (AREA)
Botany (AREA)
Mycology (AREA)
Emergency Medicine (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Medicines Containing Plant Substances (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

CZ20033042A 2003-11-10 2003-11-10 Potravinový doplněk na bázi silymarinu CZ20033042A3 (cs)

Priority Applications (6)

Application Number	Priority Date	Filing Date	Title
CZ20033042A CZ20033042A3 (cs)	2003-11-10	2003-11-10	Potravinový doplněk na bázi silymarinu
SK32-2004A SK322004A3 (sk)	2003-11-10	2004-01-13	Potravinový doplnok na báze silymarína
SK50027-2009U SK5336Y1 (en)	2003-11-10	2004-01-13	Food supplement based on silymarin
PL370897A PL205939B1 (pl)	2003-11-10	2004-10-26	Kompozycja odżywcza na bazie silymarinu
DE102004054133A DE102004054133A1 (de)	2003-11-10	2004-11-08	Nahrungsergänzungsmittel auf der Basis von Silymarin
DE202004021241U DE202004021241U1 (de)	2003-11-10	2004-11-08	Nahrungsergänzungsmittel auf der Basis von Silymarin

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CZ20033042A CZ20033042A3 (cs)	2003-11-10	2003-11-10	Potravinový doplněk na bázi silymarinu

Publications (2)

Publication Number	Publication Date
CZ295149B6 CZ295149B6 (cs)	2005-06-15
CZ20033042A3 true CZ20033042A3 (cs)	2005-06-15

Family

ID=34558488

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CZ20033042A CZ20033042A3 (cs)	2003-11-10	2003-11-10	Potravinový doplněk na bázi silymarinu

Country Status (4)

Country	Link
CZ (1)	CZ20033042A3 (pl)
DE (1)	DE102004054133A1 (pl)
PL (1)	PL205939B1 (pl)
SK (2)	SK5336Y1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITBA20080008A1 (it)	2008-02-22	2009-08-23	Michele Barone	Composizioni comprendenti fitoestrogeni selettivi per il recettore estrogenico beta e fibre dietetiche
WO2009110816A1 (ru) *	2008-03-04	2009-09-11	Dikovskiy Aleksander Vladimiro	Фармацевтическая композиция на основе гепатопротектора и пребиотика, получение и применение
ITMI20130425A1 (it) *	2013-03-20	2014-09-21	Istituto Biochimico Italiano	Composizione per il trattamento della sindrome metabolica e delle alterazioni metabolico-ossidative nei pazienti con steatoepatite non alcolica (nash)

2003
- 2003-11-10 CZ CZ20033042A patent/CZ20033042A3/cs not_active IP Right Cessation
2004
- 2004-01-13 SK SK50027-2009U patent/SK5336Y1/sk unknown
- 2004-01-13 SK SK32-2004A patent/SK322004A3/sk unknown
- 2004-10-26 PL PL370897A patent/PL205939B1/pl unknown
- 2004-11-08 DE DE102004054133A patent/DE102004054133A1/de not_active Withdrawn

Also Published As

Publication number	Publication date
CZ295149B6 (cs)	2005-06-15
DE102004054133A1 (de)	2005-06-09
PL205939B1 (pl)	2010-06-30
SK5336Y1 (en)	2010-01-07
PL370897A1 (pl)	2005-05-16
SK322004A3 (sk)	2005-06-02
SK500272009U1 (en)	2009-07-06

Legal Events

Date	Code	Title	Description
2022-06-01	MM4A	Patent lapsed due to non-payment of fee	Effective date: 20211110

Publication	Publication Date	Title
Al-Madhagy et al.	2023	A comprehensive review of the health benefits of flaxseed oil in relation to its chemical composition and comparison with other omega-3-rich oils
Basch et al.	2007	Flax and flaxseed oil (Linum usitatissimum): a review by
Spahr et al.	2022	Impact of health and lifestyle food supplements on periodontal tissues and health
Naureen et al.	2022	Dietary supplements in neurological diseases and brain aging
CA2420835A1 (en)	2002-03-07	Composition and method for treatment of hypertriglyceridemia
WO2017032270A1 (zh)	2017-03-02	预防和/或治疗心脑血管疾病的组合物
CA2847543C (en)	2018-05-15	Annatto extract compositions, including geranyl geraniols and methods of use
Elmnan et al.	2012	Effect of fenugreek (Trigonella foenm greacum) seed dietary levels on lipid profile and body weight gain of rats
CN100506088C (zh)	2009-07-01	延缓衰老的保健组合物
Al-Attar	2010	Physiological effects of some plant oils supplementation on streptozotocin-induced diabetic rats
US20100239660A1 (en)	2010-09-23	Product and use of omega-3s matching human tissue ratios for treatment of inflammatory and other conditions
CZ20033042A3 (cs)	2005-06-15	Potravinový doplněk na bázi silymarinu
Sachan et al.	2021	Ethnomedicinal Uses, Phytochemistry, Pharmacological Effects, Pre-clinical and Clinical Studies on Flaxseed: A Spice with Culinary Herbbased Formulations and its Constituents
Ibrahim et al.	2025	A Comparative Study On The Effects Of Dietary Supplementation With Garlic (Allium Sativum) And Clove (Syzygium Aromaticum) On Ghrelin Levels And Some Physiological Parameters.
TW201004637A (en)	2010-02-01	A food formula to slow the aging process
Abdul Latif et al.	2018	Selected natural agents used for cholesterol controls
US20250339472A1 (en)	2025-11-06	Mind and Body Healing Synergistic Phytomedical Formulation
Leyva et al.	2011	Medicinal use of hempseeds (Cannabis sativa L.): effects on platelet aggregation
CZ297984B6 (cs)	2007-05-16	Potravinový doplnek na bázi silymarinu
Nair et al.	2022	General Classification and Basic Clinical Information Pertaining to Nutraceuticals and Dietary Supplements against Various Diseases
CZ293046B6 (cs)	2004-01-14	Potravní doplněk s účinkem na plazmové lipidy a antioxidační kapacitu krve
RU2211043C2 (ru)	2003-08-27	Композиция для приготовления лекарственных форм и обогащения продуктов питания, способствующая коррекции нарушений липидного обмена, профилактики и лечения атеросклероза
Das et al.	2026	Beneficial Effect of Nutraceuticals on Diabetes Mellitus
Farer	0	Tiny Crustacean Reaps Hefty Health Benefits Extract from Shrimp-like Creature Proven Superior to Fish Oil
Saini	2018	Functional Foods for Replacing Chemical Filled Medicines